Time to Akt: Superior tumor-reactive T cells for adoptive immunotherapy

OncoImmunology

Volumn 4, Issue 5, 2015, Pages

  van der Waart, Anniek B ^a   Hobo, Willemijn ^a   Dolstra, Harry ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adoptive T cell therapy; Akt; Dendritic cell; IL 15; IL 7; Stem cell transplantation; T cell differentiation; Wnt

Indexed keywords

CHIMERIC ANTIGEN RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 7; MINOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELL; EFFECTOR CELL; HUMAN; MEMORY T LYMPHOCYTE; NONHUMAN; RELAPSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR RECURRENCE; VACCINATION;

EID: 84944463345     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2014.1003016     Document Type: Article

References (10)

1. Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building the ultimate antitumour T cell. Nature Reviews Cancer 2012; 12: 671-84; PMID:22996603; http://dx.doi.org/10.1038/nrc3322
2. Klebanoff CA, Gattinoni L, Restifo NP. Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy? J Immunotherapy 2012; 35: 651-60; http://dx.doi.org/10.1097/ CJI.0b013e31827806e6
3. Stemberger C, Neuenhahn M, Gebhardt FE, Schiemann M, Buchholz VR, Busch DH. Stem cell-like plasticity of naive and distinct memory CD8+ T cell subsets. Semin Immunol 2009; 21: 62-8; PMID:19269852; http://dx.doi.org/10.1016/j. smim.2009.02.004
4. Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nature Rev Cancer 2004; 4: 371-80; http://dx.doi.org/10.1038/nrc1365
5. June CH, Maus MV, Plesa G, Johnson LA, Zhao Y, Levine BL, Grupp SA, Porter DL. Engineered T cells for cancer therapy. Cancer Immunol Immunother: CII 2014; 63: 969-75; http://dx.doi.org/10.1007/s00262-014-1568-1
6. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigley MF, Almeida JR, Gostick E, Yu Z, Carpenito C, et al. A human memory T cell subset with stem cell-like properties. Nat Med 2011; 17: 1290-7; PMID:21926977; http://dx.doi.org/10.1038/ nm.2446
7. Cieri N, Camisa B, Cocchiarella F, Forcato M, Oliveira G, Provasi E, Bondanza A, Bordignon C, Peccatori J, Ciceri F, et al. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood 2013; 121: 573-84; PMID:23160470; http://dx.doi.org/10.1182/blood-2012-05-431718
8. van der Waart AB, van de Weem NM, Maas F, Kramer CS, Kester MG, Falkenburg JH, Schaap N, Jansen JH, van der Voort R, Gattinoni L, et al. Inhibition of Aktsignaling promotes the generation of superior tumorreactive T cells for adoptive immunotherapy. Blood 2014; 124(23): 3490-500; PMID:25336630; http:// dx.doi.org/10.1182/blood-2014-05-578583
9. Crompton JG, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil R, Tran E, Hanada KI, Yu Z, Palmer DC, et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res 2015; 75(2): 296-305; PMID:25432172; http://dx.doi.org/10.1158/0008-5472.CAN-14-2277
10. Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN. Clinical use of dendritic cells for cancer therapy. Lancet Oncol 2014; 15: e257-67; PMID:24872109; http://dx.doi.org/10.1016/S1470-2045(13)70585-0